Evidence map›Paper›PMID 39404347›Full record

ArticleAntimicrobial agents and chemotherapy2024

The point mutation A1387G in the 16S rRNA gene confers aminoglycoside resistance in

Michael Zarske, Christiane Werckenthin, Julia C Golz, Kerstin Stingl

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Antimicrobial use onFrontiers in microbiology · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael ZarskeGerman Federal Institute for Risk Assessment (BfR), Department of Biological Safety, National Reference Laboratory for Campylobacter, Berlin, Germany.ORCID 0000-0003-4691-0483
Christiane WerckenthinLower Saxony State Office for Consumer Protection and Food Safety (LAVES), Food and Veterinary Institute, Oldenburg, Germany.
Julia C GolzGerman Federal Institute for Risk Assessment (BfR), Department of Biological Safety, National Reference Laboratory for Campylobacter, Berlin, Germany.
Kerstin StinglGerman Federal Institute for Risk Assessment (BfR), Department of Biological Safety, National Reference Laboratory for Campylobacter, Berlin, Germany.ORCID 0000-0002-8338-717X

Funding

BMEL | Bundesinstitut für Risikobewertung (BfR) 1322-770Bundesministerium für Bildung und Forschung (BMBF) 031B0917A
6 · The paper itself

Abstract

Thermotolerant

Indexed as

AminoglycosidesAnti-Bacterial AgentsCampylobacter coliCampylobacter jejuniMicrobial Sensitivity TestsPoint MutationRNA, Ribosomal, 16STobramycinAnimalsCampylobacter InfectionsDrug Resistance, BacterialGentamicinsKanamycinNebramycinTurkeysWhole Genome SequencingAminoglycosidesAnti-Bacterial AgentsapramycinGentamicinsKanamycinNebramycinRNA, Ribosomal, 16STobramycinaminoglycosidesantibiotic resistanceCampylobacterdiagnosticsDNA sequencingfood-borne pathogensmolecular genetics

Identifiers

PMID39404347
PMCPMC11539217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.